Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from NEUSOFT XIKANG HOLDINGS INC. ( (HK:9686) ).
Xikang Cloud Hospital reported 2025 revenue of RMB464.1 million, down 7.4% year-on-year, with gross margin slipping to 27.3%. Despite the top-line decline, tighter receivables management, economies of scale in nursing services, and digital and AI-driven efficiency gains helped narrow net loss by 53.9% to RMB38.6 million, with adjusted net loss also significantly reduced.
Management framed 2025 as a pivotal year, shifting from scale expansion to quality enhancement and value realization amid China’s structural healthcare transformation and rising demand for home-based care. By deepening government collaboration on city cloud hospital platforms, rolling out replicable standardized systems, and launching voucher-linked inclusive healthcare models, the company reinforced its leadership in home medical and nursing services while turning its health data platforms from cost centers into value drivers and keeping operating cash flow positive.
The most recent analyst rating on (HK:9686) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on NEUSOFT XIKANG HOLDINGS INC. stock, see the HK:9686 Stock Forecast page.
More about NEUSOFT XIKANG HOLDINGS INC.
Xikang Cloud Hospital Holdings Inc., formerly Neusoft Xikang Holdings Inc., operates in China’s healthcare and digital medical services sector. The company focuses on home-based medical and nursing care, leveraging city-specific cloud hospital platforms, AI-enabled operations, and partnerships with local governments to deliver integrated medical, nursing, and home care services.
Average Trading Volume: 16,685
Technical Sentiment Signal: Sell
Current Market Cap: HK$707.2M
Learn more about 9686 stock on TipRanks’ Stock Analysis page.

